INTRuST   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: La Jolla CA United States

Organization Overview

First Clinical Trial
2011
NCT01339689
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium

Active Ingredients

Drugs in Phase 4 Trials (1)

tramadol (Ultram) (1 trial)

Drugs in Phase 2 Trials (4)

galantamine (reminyl) (1 trial)

ganaxolone (Ztalmy) (1 trial)

glyburide (micronase) (1 trial)

methylphenidate (ritalin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5